↓ Skip to main content

Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?

Overview of attention for article published in CNS Drugs, March 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
68 Mendeley
Title
Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?
Published in
CNS Drugs, March 2017
DOI 10.1007/s40263-017-0411-6
Pubmed ID
Authors

David M. Taylor

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 21%
Student > Bachelor 9 13%
Researcher 8 12%
Other 6 9%
Student > Ph. D. Student 6 9%
Other 8 12%
Unknown 17 25%
Readers by discipline Count As %
Medicine and Dentistry 16 24%
Nursing and Health Professions 9 13%
Psychology 6 9%
Agricultural and Biological Sciences 5 7%
Neuroscience 5 7%
Other 7 10%
Unknown 20 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2022.
All research outputs
#2,892,214
of 22,908,162 outputs
Outputs from CNS Drugs
#246
of 1,305 outputs
Outputs of similar age
#55,952
of 310,225 outputs
Outputs of similar age from CNS Drugs
#4
of 18 outputs
Altmetric has tracked 22,908,162 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,305 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,225 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.